These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11684575)

  • 41. Aristolochic acid-related nephropathy associated with the popular Chinese herb Xi Xin.
    Yang HY; Lin JL; Chen KH; Yu CC; Hsu PY; Lin CL
    J Nephrol; 2006; 19(1):111-4. PubMed ID: 16523436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute renal failure due to an aristolochic acid containing herbal remedy.
    Hutton H; Dowling J; Kerr P
    Nephrology (Carlton); 2012 Jul; 17(5):522-3. PubMed ID: 22725717
    [No Abstract]   [Full Text] [Related]  

  • 43. [Case of traditional herbal medicine-induced aristolochic acid nephropathy developing to end-stage renal failure].
    Fujimura T; Tamaki K; Iida S; Tanaka H; Ikedou H; Takamiya Y; Kato S; Tanaka A; Okuda S
    Nihon Jinzo Gakkai Shi; 2005; 47(4):474-80. PubMed ID: 15971892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference.
    Yang HY; Chen PC; Wang JD
    Biomed Res Int; 2014; 2014():569325. PubMed ID: 25431765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Nephropathy associated with Chinese herbal drugs. 2 cases].
    Pourrat J; Montastruc JL; Lacombe JL; Cisterne JM; Rascol O; Dumazer P
    Presse Med; 1994 Nov; 23(36):1669. PubMed ID: 7899296
    [No Abstract]   [Full Text] [Related]  

  • 46. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.
    Cosyns JP
    Drug Saf; 2003; 26(1):33-48. PubMed ID: 12495362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The clinical and pathological manifestations of aristolochic acid nephropathy--the report of 58 cases].
    Chen W; Chen Y; Li A
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(18):1101-5. PubMed ID: 11766606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Aristolochic acid nephropathy].
    Witkowicz J
    Przegl Lek; 2009; 66(5):253-6. PubMed ID: 19739583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure.
    Nortier JL; Schmeiser HH; Muniz Martinez MC; Arlt VM; Vervaet C; Garbar CH; Daelemans P; Vanherweghem JL
    Nephrol Dial Transplant; 2003 Feb; 18(2):426-8. PubMed ID: 12543902
    [No Abstract]   [Full Text] [Related]  

  • 50. [A young woman with kidney failure].
    Øvrehus MA; Spigset O; Zahlsen K; Brunsvik A; Aarset H; Aasarød K
    Tidsskr Nor Laegeforen; 2011 Oct; 131(19):1897-9. PubMed ID: 21984296
    [No Abstract]   [Full Text] [Related]  

  • 51. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Breuer A; Bieler CA; Schmeiser HH
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):421-7. PubMed ID: 10445409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chinese herbal medicines, aristolochic acid and Balkan endemic nephropathy.
    Pitt JI
    Occup Environ Med; 2011 Apr; 68(4):237. PubMed ID: 21242276
    [No Abstract]   [Full Text] [Related]  

  • 53. Aristolochic acid nephropathy: what we know and what we have to do.
    Li X; Wang H
    Nephrology (Carlton); 2004 Jun; 9(3):109-11. PubMed ID: 15189168
    [No Abstract]   [Full Text] [Related]  

  • 54. Outbreak of Chinese herb nephropathy in Japan: are there any differences from Belgium?
    Tanaka A; Nishida R; Yoshida T; Koshikawa M; Goto M; Kuwahara T
    Intern Med; 2001 Apr; 40(4):296-300. PubMed ID: 11334387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chinese herbs: risk, side effects, and poisoning: the case for objective reporting and analysis reveals serious misrepresentation.
    McIntyre M
    J Altern Complement Med; 1998; 4(1):15-6. PubMed ID: 9553831
    [No Abstract]   [Full Text] [Related]  

  • 56. [Aristolochic acid nephropathy ("Chinese herb nephropathy")].
    Nortier J; Pozdzik A; Roumeguere T; Vanherweghem JL
    Nephrol Ther; 2015 Dec; 11(7):574-88. PubMed ID: 26515658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Dangerous herbs?].
    Fossum G
    Tidsskr Nor Laegeforen; 2011 Oct; 131(19):1900. PubMed ID: 21984297
    [No Abstract]   [Full Text] [Related]  

  • 58. Time to abandon the term "Chinese herbs nephropathy".
    Chen HY; Ma BY; Grant A; Lampert N
    Kidney Int; 2001 Nov; 60(5):2039-40. PubMed ID: 11703630
    [No Abstract]   [Full Text] [Related]  

  • 59. Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer.
    Arlt VM; Alunni-Perret V; Quatrehomme G; Ohayon P; Albano L; Gaïd H; Michiels JF; Meyrier A; Cassuto E; Wiessler M; Schmeiser HH; Cosyns JP
    Int J Cancer; 2004 Oct; 111(6):977-80. PubMed ID: 15300815
    [No Abstract]   [Full Text] [Related]  

  • 60. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Hájek M; Frei E; Schmeiser HH
    Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.